|
Update:
The last geezer with a laser was Obi-Wan Kenobi
I just picked up a hot rumor on Cell Robotics. Cell Robotics (CRII:Bulletin Boards), as you remember, makes a laser lancet that draws blood from your finger. It is safer and less painful than the steel lancets currently in use.
The rumor is that the American Association of Retired People (AARP) will be marketing the Cell Robotics product to its 34 million members. The deal supposedly is a profit sharing arrangement, whereas it would be to AARP's benefit to sell the Lasette at a markup.
This is just frivolous speculation, but considering that CRII has a market capitalization of US$42 million and a float of only 5.5 million, exposure to more than 34 million folks has to be worth a couple of points on the press release. That's not even taking into consideration the percentage of diabetics who will actually purchase the product.
CRII remains a strong buy under US$5.
To keep up with the latest changes and updates to the Taipan website, make sure you're subscribed to e-dispatch, Taipan's free daily email alert service. To subscribe to the service, click here.
In addition to his duties at Taipan, Chris DeHaemer is the editor of The Hammer.
|
